XT
LGND icon

XTX Topco’s Ligand Pharmaceuticals LGND Stock Holding History

XTX Topco’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247K Sell
1,237
-6,480
-84% -$1.28M ﹤0.01% 2661
2025
Q4 		$1.46M Buy
+7,717
New +$1.48M 0.04% 763
2025
Q1 		– Sell
-3,067
Closed -$329K – 2767
2024
Q4 		$329K Buy
+3,067
New +$347K 0.03% 1141
2023
Q3 		– Sell
-6,161
Closed -$444K – 1801
2023
Q2 		$444K Buy
6,161
+2,220
+56% +$167K 0.08% 441
2023
Q1 		$290K Buy
+3,941
New +$280K 0.06% 677

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

XTX Topco's LGND Position: Q1 2026 in Review

XTX Topco reduced its Ligand Pharmaceuticals (LGND) stake by 84% in Q1 2026, selling an estimated $1.28M and leaving 1,237 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #2661.

XTX Topco first reported a position in LGND in Q1 2023 and has held it in 5 quarters since. The position peaked at $1.46M in Q4 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • XTX Topco held 1,237 shares of Ligand Pharmaceuticals worth $247K as of Q1 2026.
  • XTX Topco sold 6,480 Ligand Pharmaceuticals shares in Q1 2026, an estimated $1.28M.
  • Ligand Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2661 holding.
  • XTX Topco first reported a position in Ligand Pharmaceuticals in Q1 2023 and has held it in 5 quarters since.
  • XTX Topco's Ligand Pharmaceuticals position peaked at $1.46M in Q4 2025.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.